Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Access Enters RNAi Delivery Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Access Enters RNAi Delivery Pact

Access Pharmaceuticals, Inc. has entered into an agreement with a major pharmaceutical company to use its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Access Pharmaceuticals, Inc. has entered into an agreement with a major pharmaceutical company to use its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics. Access will provide CobOral and CobaCyte siRNA formulations for evaluation of gene knockdown following oral and intravenous administration. According to Access, any successful formulation developed will be jointly owned and subject to a subsequent full licensing agreement. Terms of the agreement were not disclosed.

“We have made great progress in our CobOral and CobaCyte siRNA delivery programs over the past year, demonstrating the efficiency and safe delivery needed for a viable RNAi therapeutic,” said Jeffrey B. Davis, president and chief executive officer, Access Pharmaceuticals, Inc. “The signing of this agreement serves as further validation of our previous work related to our CobaCyte technology’s unique ability to deliver inactivated siRNA particles to disease target sites.We believe our innovative approach is well-suited for this pharmaceutical company and look forward to the collaborative work ahead.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics